These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25743999)

  • 1. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens.
    Pogue JM; Kaye KS; Cohen DA; Marchaim D
    Clin Microbiol Infect; 2015 Apr; 21(4):302-12. PubMed ID: 25743999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens.
    Fraimow HS; Tsigrelis C
    Crit Care Clin; 2011 Jan; 27(1):163-205. PubMed ID: 21144992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.
    Thabit AK; Crandon JL; Nicolau DP
    Expert Opin Pharmacother; 2015 Feb; 16(2):159-77. PubMed ID: 25496207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
    Rolston KV
    Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance: factors and outcomes.
    Fish DN; Ohlinger MJ
    Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
    McDonald LC
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of broad-spectrum antimicrobials for the treatment of pneumonia in seriously ill patients: maximizing clinical outcomes and minimizing selection of resistant organisms.
    Niederman MS
    Clin Infect Dis; 2006 Jan; 42 Suppl 2():S72-81. PubMed ID: 16355320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting "older" antimicrobials in the era of multidrug resistance.
    Pogue JM; Marchaim D; Kaye D; Kaye KS
    Pharmacotherapy; 2011 Sep; 31(9):912-21. PubMed ID: 21923592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of the ESKAPE pathogens.
    Pendleton JN; Gorman SP; Gilmore BF
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):297-308. PubMed ID: 23458769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region.
    Hsueh PR; Hoban DJ; Carmeli Y; Chen SY; Desikan S; Alejandria M; Ko WC; Binh TQ
    J Infect; 2011 Aug; 63(2):114-23. PubMed ID: 21669223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of antimicrobial resistance.
    Harbottle H; Thakur S; Zhao S; White DG
    Anim Biotechnol; 2006; 17(2):111-24. PubMed ID: 17127523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoinactivation of ESKAPE pathogens: overview of novel therapeutic strategy.
    Nakonieczna J; Wozniak A; Pieranski M; Rapacka-Zdonczyk A; Ogonowska P; Grinholc M
    Future Med Chem; 2019 Mar; 11(5):443-461. PubMed ID: 30901231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The food safety perspective of antibiotic resistance.
    McDermott PF; Zhao S; Wagner DD; Simjee S; Walker RD; White DG
    Anim Biotechnol; 2002 May; 13(1):71-84. PubMed ID: 12212946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losing ground: multidrug-resistant bacteria in solid-organ transplantation.
    Herati RS; Blumberg EA
    Curr Opin Infect Dis; 2012 Aug; 25(4):445-9. PubMed ID: 22766649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.